Skip to content
The Nexus
BUSINESSJul 16 · 11:41 UTCBLOOMBERGAnna Edney

Abbott Boosts 2026 Profit Guidance as Sales Across Business Rise

Abbott Laboratories increased its 2026 profit guidance due to a stronger-than-expected second quarter driven by improved performance across most business lines.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting

Abbott Boosts 2026 Profit Guidance as Sales Across Business Rise · The Nexus